ZHOU Ying,SHI Yang,XIE Hui-di,et al.Mechanism of Qiditangshen Formula for improving high glucose-induced endoplasmic reticulum stress in MPC5 cell by inhibiting IRE1α/XBP1s[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(11):1209-1215.
ZHOU Ying,SHI Yang,XIE Hui-di,et al.Mechanism of Qiditangshen Formula for improving high glucose-induced endoplasmic reticulum stress in MPC5 cell by inhibiting IRE1α/XBP1s[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(11):1209-1215. DOI: 10.16025/j.1674-1307.2022.11.002.
Mechanism of Qiditangshen Formula for improving high glucose-induced endoplasmic reticulum stress in MPC5 cell by inhibiting IRE1α/XBP1s
Objective,2,To explore whether Qiditangshen Formula can inhibit MPC5 endoplasmic reticulum stress (ERS) induced by high glucose through IRE1α/XBP1s pathway.,Methods,2,MPC5 cells were studied and CCK-8 method was used to screen the concentration and time of high glucose model and the best concentration of Qiditangshen Formula intervention. MPC5 cells were divided into control group,model group and Qiditangshen group. They were cultured in complete medium,35 mmol/L high sugar medium, 35 mmol/L high sugar medium+ Qiditangshen, respectively. Western blot was used to detect the protein expression changes of TXNIP, NLRP3 and endoplasmic reticulum stress related pathway, such as p-IRE1α,IRE1α, XBP1s,p-PERK,PERK,ATF6 protein in podocytes.,Results,2,Compared with the control group, the expression levels of p-IRE1α/IRE1α,p-PERK/PERK,XBP1s,TXNIP,NLRP3 proteins were significantly higher in the model group of MPC5 cells(,P,<,0.01,,P,<,0.05),the expression of ATF6 had an upward trend but the difference had no statistical significance(,P,>,0.05). Compared with the model group, Qiditangshen Formula group could significantly reduce p-IRE1α/IRE1α,XBP1s,TXNIP,NLRP3 proteins expression level of MPC5 cells induced by high glucose(,P,<,0.01,,P,<,0.05), but the differences in expression of p-PERK/PERK and ATF6 protein had no statistical significancece(,P,>,0.05).,Conclusion,2,Qiditangshen Formula can improve the ERS of MPC5 cells induced by high glucose,and the mechanism is closely related to the inhibition of the overexpression of IRE1α/XBP1s pathway and TXNIP,NLRP3 proteins downstream.
MA CE , YU P , WEI W, et al. Efficacy of combined angiotensin II receptor blocker with tripterygium glycosides on diabetic nephropathy: A protocol for meta-analysis[J]. Medicine, 2021,100(22):e25991.
LIMONTE CP, KRETZLER M, PENNATHUR S, et al. Present and future directions in diabetic kidney disease[J]. J Diabetes Complications.2022;36(12):108357.
AHMADIAN E, EFTEKHARI A, ATAKISHIZADA S, et al. Podocytopathy: The role of actin cytoskeleton[J]. Biomed Pharmacother.2022,156:113920.
LAL MA, PATRAKKA J. Understanding podocyte biology to develop novel kidney therapeutics[J].Front Endocrinol(Lausanne),2018,9:409.
CAO Y, HAO Y, LI H, et al. Role of endoplasmic reticulum stress in apoptosis of differentiated mouse podocytes induced by high glucose [J]. Int J Mol Med,2014,33(4):809-816.
NI L, YUAN C, WU X. Endoplasmic reticulum stress in diabetic nephrology: regulation, pathological role, and therapeutic potential[J]. Oxid Med Cell Longev,2021,2021:7277966.
SANKRITYAYAN H, OZA MJ, KULKARNI YA, et al. ER stress response mediates diabetic microvascular complications[J]. Drug Discov Today,2019,24(12):2247-2257.
WALTER P,RON D.The unfolded protein response:from stress pathway to homeostatic regulation[J].Science,2011,334(6059):1081-1086.
SONG S, QIU D, SHI Y, et al. Thioredoxin-interacting protein deficiency alleviates phenotypic alterations of podocytes via inhibition of mTOR activation in diabetic nephropathy[J]. J Cell Physiol,2019.doi:10.1002/jcp.28317http://dx.doi.org/10.1002/jcp.28317.
XIANG Y, WANG Z, HUI Q, et al. DNA methylation of TXNIP independently associated with inflammation and diabetes mellitus in twins[J]. Twin Res Hum Genet,2021(2):1-8.
SONG Y, GUO F, ZHAO Y, et al. Verapamil ameliorates proximal tubular epithelial cells apoptosis and fibrosis in diabetic kidney[J]. Eur J Pharmacol,2021,911:174552.
HE Q, LI Y, ZHANG W, et al. Role and mechanism of TXNIP in ageing-related renal fibrosis[J]. Mech Ageing Dev,2021,196:111475.
WANG X, ZHAO L, AJAY AK, et al. Qiditangshen Granules activate renal nutrient-sensing associated autophagy in db/db mice[J]. Front Physiol,2019,10:1224.
SHANKLAND SJ, PIPPIN JW, REISER J, et al. Podocytes in culture: past, present, and future[J]. Kidney Int,2007;72(1):26-36.
童楠. 益肾颗粒调控足细胞自噬改善糖尿病肾病的作用机制研究[D].北京:中国中医科学院,2018.
MUNDEL P, REISER J, ZÚÑIGA MEJÍA BORJA A, et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines[J]. Exp Cell Res,1997,236(1):248-258.
LAL MA, PATRAKKA J. Understanding podocyte biology to develop novel kidney therapeutics[J]. Front Endocrinol (Lausanne),2018(9):409.
KIM JS, HAN BG, CHOI SO, et al. Secondary focal segmental glomerulosclerosis: from podocyte injury to glomerulosclerosis[J]. Biomed Res Int,2016:1630365.
LERNER AG, UPTON JP, PRAVEEN PV, et al. IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress[J]. Cell Metab,2012,16(2):250-264.
Effect and the mechanism of Qiwei Granules on renal function in KK-Ay mice with spontaneous type 2 diabetes
Mechanism of Astragaloside IV on diabetic nephropathy induced by Streptozotocin in rats
Regulatory effect of schisandrin B on myocardial cells with hypoxia/reoxygenation- induced injury in neonatal rats through suppressing endoplasmic reticulum stress
Effects of Tangshenning on expression of nephrin and synaptopodin of podocyte in diabetic kidney disease mice
Related Author
No data
Related Institution
National Center for Geriatric Diseases,Beijing Hospital
School of Traditional Chinese Medicine,Beijing Key Lab of TCM Collateral Research,Capital Medical University
Department of Traditional Chinese Medicine and Acupuncture, Beijing Tiantan Hospital, Capital Medical University
Institute of Clinical Medicine, China-Japan Friendship Hospital
Cardiovascular Medicine Center,Central Hospital of Enshi Autonomous Prefecture